1,333 articles
Over 3,000 carriers of the top Alzheimer's risk gene will track lifestyle and cognition for years in a landmark real-world study.
REP-0003 targets toxic intracellular cholesterol in artery walls — a rare disease breakthrough with wide cardiovascular aging implications.
A study of 2,000+ older adults finds lower blood vitamin C tied to less gray matter and weaker memory-related brain networks.
The FDA expanded approval of Casgevy, a CRISPR-based gene therapy, to children aged 2+ with sickle cell disease, offering a potential cure.
The OPTIMA trial shows genomic testing could safely help more women with early breast cancer skip chemo, including premenopausal women.
A major global study finds BMI-linked gaps in blood pressure and cholesterol have nearly vanished for older adults — but young adults remain at elevated risk.
Tregzi, a personalized T cell therapy, wins FDA approval to reduce dangerous immune complications in blood cancer stem cell transplant patients.
A 25-year Lancet study finds adults over 40 with obesity now show cardiovascular markers rivaling normal-weight peers, thanks to medications.
From a 20% lifespan boost in mice to Alzheimer's glycosylation hallmarks, June's research roundup delivers dense longevity science.
A new review of 5 clinical trials finds creatine may boost mood in some women with depression, but results are inconsistent across groups.
Research shows a single high-fat meal impairs artery function and spikes lung inflammation within hours, raising cardiovascular risk.
Tregzi slashes chronic graft-versus-host disease rates from 44% to 12.6%, offering new hope for stem cell transplant patients.
